US Bancorp’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,505
Closed -$490K 4140
2024
Q1
$490K Buy
1,505
+527
+54% +$129K ﹤0.01% 1518
2023
Q4
$186K Buy
978
+262
+37% +$49.5K ﹤0.01% 2043
2023
Q3
$143K Buy
716
+4
+0.6% +$946 ﹤0.01% 1978
2023
Q2
$203K Sell
712
-3,536
-83% -$982K ﹤0.01% 1857
2023
Q1
$921K Buy
4,248
+144
+4% +$28.1K ﹤0.01% 1116
2022
Q4
$844K Buy
4,104
+477
+13% +$121K ﹤0.01% 1135
2022
Q3
$1.01M Sell
3,627
-5,137
-59% -$1.31M ﹤0.01% 1043
2022
Q2
$1.68M Buy
8,764
+2,238
+34% +$395K ﹤0.01% 879
2022
Q1
$1.35M Buy
6,526
+5,106
+360% +$842K ﹤0.01% 1052
2021
Q4
$253K Sell
1,420
-179
-11% -$35.3K ﹤0.01% 1861
2021
Q3
$328K Sell
1,599
-68
-4% -$13.4K ﹤0.01% 1732
2021
Q2
$316K Buy
1,667
+153
+10% +$25K ﹤0.01% 1778
2021
Q1
$197K Buy
1,514
+158
+12% +$19K ﹤0.01% 1924
2020
Q4
$141K Buy
1,356
+690
+104% +$59.8K ﹤0.01% 2036
2020
Q3
$51K Buy
666
+131
+24% +$7.43K ﹤0.01% 2393
2020
Q2
$26K Sell
535
-751
-58% -$30.9K ﹤0.01% 2708
2020
Q1
$43K Buy
+1,286
New +$51.1K ﹤0.01% 2423

Other funds holding SWAV

US Bancorp's SWAV Position: Q2 2024 in Review

US Bancorp sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,505 shares — an estimated $490K sold.

US Bancorp first reported a position in SWAV in Q1 2020 and held it in 17 quarters. The position peaked at $1.68M in Q2 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • US Bancorp reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • US Bancorp sold 1,505 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $490K.
  • US Bancorp first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2020 and held it in 17 quarters.
  • US Bancorp's Shockwave Medical, Inc. Common Stock position peaked at $1.68M in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on US Bancorp's 13F filing for Q2 2024, filed 7 Aug 2024.